Study Information
Status: Active, Recruiting
Study Details
View study details on clinicaltrials.gov.
Locations
Palo Alto/Santa Cruz, San Mateo, East Bay, San Francisco, Mills-Peninsula, Greater Sacramento Valley, Santa Rosa, Modesto, Solano/Vallejo
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
SWOG S1900J: A Phase II Study of Amivantamab in Participants With MET Amplification-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY)
Principal Investigator
Related Studies
The Impact of Smoking, Comorbidities, and Race/Ethnicity on COVID-19 Infection and Disease Severity
Using EHR from a large healthcare system in Northern CA, we will study the impact of smoking, comorbidities, race on COVID-19 infection and disease severity.
Investigator: Jiang Li, Ph.D., MPH